Characteristics |
Frequency |
Percent |
Lymphocytic infiltration |
Less than 25% (+1) in necropsy samples |
6 |
40.0 |
25%-50% (+2) in necropsy samples |
8 |
53.3 |
More than 50% (+3) in necropsy samples |
1 |
6.7 |
Location of Infiltrate |
Alveolar septa |
6 |
40.0 |
Alveolar septa+perivascular |
9 |
60.0 |
Microthrombi |
Absent |
12 |
80.0 |
Present |
3 |
20.0 |
Anthracosis |
Absent in necropsy samples |
2 |
13.3 |
Less than 25% (+1) in necropsy samples |
10 |
66.7 |
25%-50% (+2) in necropsy samples |
3 |
20.0 |
Desquamated type2 pneumocytes |
Absent in necropsy samples |
4 |
26.7 |
Less than 25% (+1) in necropsy samples |
6 |
40.0 |
25%-50% (+2) in necropsy samples |
3 |
20.0 |
More than 50% (+3) in necropsy samples |
2 |
13.3 |
Viral inclusion cytopathic effects |
Absent |
11 |
73.3 |
Present |
4 |
26.7 |
Hyaline membrane changes |
Absent in necropsy samples |
3 |
20.0 |
Less than 25% (+1) in necropsy samples |
6 |
40.0 |
25%-50% (+2) in necropsy samples |
4 |
26.7 |
More than 50% (+3) in necropsy samples |
2 |
13.3 |
Fibrindeposition |
Absent in necropsy samples |
4 |
26.7 |
Less than 25% (+1) in necropsy samples |
8 |
53.3 |
25%-50% (+2) in necropsy samples |
3 |
20.0 |
Alveolar Capillaries |
Inflammation, edema |
2 |
13.3 |
Inflammation, edema and thrombosis |
1 |
6.7 |
Surrounded with edema |
10 |
66.6 |
surrounded with edema &PMN infiltration |
1 |
6.7 |
surrounded with edema+fibrous thickening |
1 |
6.7 |
Megakaryocytes |
Absent |
5 |
33.3 |
less than 3 in whole slide |
7 |
46.7 |
≥3 in whole slide |
3 |
20.0 |
PMN in wall |
Mild or focal |
12 |
80.0 |
Moderate |
2 |
13.3 |
Severe |
1 |
6.7 |
Septal necrosis |
Absent |
12 |
80.0 |
Extensive |
1 |
6.7 |
Focal |
2 |
13.3 |
Microabscess |
Absent |
13 |
86.7 |
Extensive |
1 |
6.7 |
Focal |
1 |
6.7 |
Bacterialcolonies |
Negative |
14 |
93.3 |
Present |
1 |
6.7 |